Reduction of coronary events in CAD with ACE inhibition. latest clinical evidence
dc.contributor.author | Purcell, H. | en_US |
dc.date.accessioned | 2013-11-27T06:30:36Z | |
dc.date.available | 2013-11-27T06:30:36Z | |
dc.date.issued | 2003 | en_US |
dc.identifier.citation | Journal of the Ceylon College of Physicians, 36(1-2):p.34-38 | en_US |
dc.identifier.uri | https://dl.nsf.gov.lk/handle/1/10108 | |
dc.publisher | Ceylon College of Physicians. Rajagiriya | en_US |
dc.subject | Medical Sciences | en_US |
dc.subject | Cardiovascular diseases | en_US |
dc.subject | Coronary artery disease | en_US |
dc.subject | Angiotensin-converting enzyme inhibition | en_US |
dc.subject | Perinodopril | en_US |
dc.subject | Positive effects | en_US |
dc.title | Reduction of coronary events in CAD with ACE inhibition. latest clinical evidence | en_US |
dc.type | A | en_US |